Lentiviral Vectors: Their Molecular Design, Safety, and Use in Laboratory and Preclinical Research

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Human Gene Therapy

• Publication date

  2011-04-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/hum.2011.058PMID 21486177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transdifferentiation of glioblastoma cells into vascular endothelial cells

  2011cited by this paper
• Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

  2011cited by this paper
• Polyclonal fluctuation of lentiviral vector-transduced and expanded murine hematopoietic stem cells.

  2011cited by this paper
• Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII.

  2011cited by this paper
• Influence of insulators on transgene expression from integrating and non-integrating lentiviral vectors

  2011cited by this paper
• Replication-competent lentivirus analysis of clinical grade vector products.

  2011cited by this paper
• Imaging stem cell-derived persistent foci after in vivo selection of lentiviral MGMT-P140K transduced murine bone marrow cells.

  2011cited by this paper
• Simple Generation of Human Induced Pluripotent Stem Cells Using Poly-β-amino Esters As the Non-viral Gene Delivery System*

  2011cited by this paper
• Polyclonal fluctuation of lentiviral vector–transduced and expanded murine hematopoietic stem cells

  2011cited by this paper
• Is normal hematopoiesis maintained solely by long-term multipotent stem cells?

  2011cited by this paper
• Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.

  2011cited by this paper
• Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector.

  2011cited by this paper
• Advances in Reprogramming Somatic Cells to Induced Pluripotent Stem Cells

  2010cited by this paper
• Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel sequencing

  2010cited by this paper
• Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

  2010cited by this paper
• Inducible Gene and shRNA Expression in Resident Hematopoietic Stem Cells In Vivo

  2010cited by this paper
• A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration.

  2010cited by this paper
• Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma.

  2010cited by this paper
• Characterisation of eGFP-transgenic BALB/c mouse strain established by lentiviral transgenesis

  2010cited by this paper
• High-Definition Mapping of Retroviral Integration Sites Defines the Fate of Allogeneic T Cells After Donor Lymphocyte Infusion

  2010cited by this paper
• Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases

  2010cited by this paper
• Development of a novel mouse glioma model using lentiviral vectors

  2009cited by this paper
• N-glycosylation engineering of biopharmaceutical expression systems.

  2009cited by this paper
• Use of HIV as a gene transfer vector.

  2009cited by this paper
• Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications

  2009cited by this paper
• Lentiviral transgenesis.

  2009cited by this paper
• Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.

  2009cited by this paper
• Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette

  2009cited by this paper
• Amelioration of Psoriasis by Anti-TNF-α RNAi in the Xenograft Transplantation Model.

  2009cited by this paper
• Polycistronic Lentiviral Vector for “Hit and Run” Reprogramming of Adult Skin Fibroblasts to Induced Pluripotent Stem Cells

  2009cited by this paper
• Preventing and exploiting the oncogenic potential of integrating gene vectors.

  2009cited by this paper
• Optimized Lentiviral Vector Design Improves Titer and Transgene Expression of Vectors Containing the Chicken β-Globin Locus HS4 Insulator Element.

  2009cited by this paper
• Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design.

  2009cited by this paper
• Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

  2009cited by this paper
• Germ-line transmission of lentiviral PGK-EGFP integrants in transgenic cattle: new perspectives for experimental embryology

  2009cited by this paper
• Forward RNAi screens in primary human hematopoietic stem/progenitor cells.

  2009cited by this paper
• Single-vector inducible lentiviral RNAi system for oncology target validation

  2009cited by this paper
• Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element.

  2009cited by this paper
• Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS

  2009cited by this paper
• The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy.

  2009cited by this paper
• Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models

  2009cited by this paper
• Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

  2008cited by this paper
• Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats

  2008cited by this paper
• Generating iPS cells from MEFS through forced expression of Sox-2, Oct-4, c-Myc, and Klf4.

  2008cited by this paper
• Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.

  2008cited by this paper
• A high-efficiency system for the generation and study of human induced pluripotent stem cells.

  2008cited by this paper
• Resistance of mature T cells to oncogene transformation.

  2008cited by this paper
• A drug-inducible system for direct reprogramming of human somatic cells to pluripotency.

  2008cited by this paper
• Construction of a high-performance human fetal liver-derived lentiviral cDNA library

  2008cited by this paper
• Applications of lentiviral vectors for shRNA delivery and transgenesis.

  2008cited by this paper
• A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice.

  2007cited by this paper
• Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study

  2007cited by this paper
• A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.

  2007cited by this paper
• Transgenic farm animals: an update.

  2007cited by this paper
• Optimization of a genome-wide disordered lentivector-based short hairpin RNA library

  2006cited by this paper
• A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Gene transfer in humans using a conditionally replicating lentiviral vector

  2006cited by this paper
• Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

  2006cited by this paper
• Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation.

  2006cited by this paper
• Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer

  2006cited by this paper
• KRAB Can Repress Lentivirus Proviral Transcription Independently of Integration Site*

  2006cited by this paper
• Is it going to be SIN?

  2006cited by this paper
• Fetal Gene Transfer Using Lentiviral Vectors: In Vivo Detection of Gene Expression by microPET and Optical Imaging in Fetal and Infant Monkeys

  2006cited by this paper
• Noninvasive molecular imaging to detect transgene expression of lentiviral vector in nonhuman primates.

  2006cited by this paper
• Genome-scale loss-of-function screening with a lentiviral RNAi library

  2006cited by this paper
• Production and Titration of Lentiviral Vectors

  2006cited by this paper
• Transgenic farm animals: present and future.

  2005cited by this paper
• Molecular strategies to inhibit HIV-1 replication

  2005cited by this paper
• Harnessing HIV for therapy, basic research and biotechnology.

  2005cited by this paper
• Regulatory Considerations for Novel Gene Therapy Products: A Review of the Process Leading to the First Clinical Lentiviral Vector

  2005cited by this paper
• Positional effects of the central DNA flap in HIV-1-derived lentiviral vectors.

  2005cited by this paper
• Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE)

  2005cited by this paper
• Lentiviral transduction of human hematopoietic cells by HIV‐1‐ and SIV‐based vectors containing a bicistronic cassette driven by various internal promoters

  2005cited by this paper
• Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.

  2005cited by this paper
• Imaging Tri-Fusion Multimodality Reporter Gene Expression in Living Subjects

  2004cited by this paper
• Highly efficient lentiviral-mediated human cytokine transgenesis on the NOD/scid background.

  2004cited by this paper
• A Hard Way to the Nucleus

  2004cited by this paper
• ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells.

  2004cited by this paper
• Safe two‐plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one‐step protocol

  2004cited by this paper
• Lentiviral transgenesis

  2004cited by this paper
• A Lentiviral cDNA Library Employing Lambda Recombination Used To Clone an Inhibitor of Human Immunodeficiency Virus Type 1-Induced Cell Death

  2004cited by this paper
• Efficient transgenesis in farm animals by lentiviral vectors

  2003cited by this paper
• Self-inactivating lentiviral vectors and a sensitive Cre-loxP reporter system.

  2003cited by this paper
• Molecular recognition of the human coactivator CBP by the HIV-1 transcriptional activator Tat.

  2003cited by this paper
• LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

  2003cited by this paper
• Identification of a novel proliferation-inducing determinant using lentiviral expression cloning.

  2003cited by this paper
• Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice.

  2003cited by this paper
• Cre/loxP recombination system and gene targeting.

  2002cited by this paper
• Transcriptional activation of interleukin-8 by beta-catenin-Tcf4.

  2002cited by this paper
• Transcriptional Activation of Interleukin-8 by β-Catenin-Tcf4*

  2002cited by this paper
• HIV-2 and SIV Vector Systems

  2001cited by this paper
• Lentivirus in the clinic.

  2001cited by this paper
• Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap

  2001cited by this paper
• Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging.

  2001cited by this paper
• The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain

  2001cited by this paper
• Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.

  2001cited by this paper
• Development of Minimal Lentivirus Vectors Derived from Simian Immunodeficiency Virus (SIVmac251) and Their Use for Gene Transfer into Human Dendritic Cells

  2000cited by this paper
• Lentiviral vectors: regulated gene expression.

  2000cited by this paper
• Stable gene transfer to the nervous system using a non-primate lentiviral vector

  1999cited by this paper

• From Ex Vivo to In Vivo: Advances in Lentiviral Vector Engineering for CAR-T Therapy.

  2026cites this paper
• In vivo engineering of CAR-T cells: delivery strategies and clinical translation

  2026cites this paper
• Multiplexed imaging of G-proteins and ERK activity upon activation of CaSR

  2025cites this paper
• Nanobody Therapeutics in Alzheimer’s Disease: From Molecular Mechanisms to Translational Approaches

  2025cites this paper
• In vivo production of CAR T cell: Opportunities and challenges

  2025cites this paper
• Interlaboratory assessment of candidate reference materials for lentiviral vector copy number and integration site measurements

  2025cites this paper
• Transduction of Lentiviral Vectors and ADORA3 in HEK293T Cells Modulated in Gene Expression and Alternative Splicing

  2025cites this paper
• Stable Expression by Lentiviral Transduction of Cells.

  2024cites this paper
• In vivo manufacture and manipulation of CAR-T cells for better druggability

  2024cites this paper
• Development of optimized cytotoxicity assays for assessing the antitumor potential of CAR-T cells.

  2023cites this paper
• The recombinase activating genes: architects of immune diversity during lymphocyte development

  2023cites this paper
• Lentiviral Vectors for Ocular Gene Therapy

  2022cites this paper
• Reference standards for accurate validation and optimization of assays that determine integrated lentiviral vector copy number in transduced cells

  2021cites this paper
• Cellular Therapy

  2021cites this paper
• Nonclinical safety assessment of engineered T cell therapies.

  2021cites this paper
• Viruses, the vehicle for cancer gene therapy: A Review

  2020cites this paper
• Molecular Cloning, Lentiviral Transduction, and Expression of Recombinant ADAMTSL2 and ADAMTSL4.

  2020cites this paper
• Cellular Therapy

  2020cites this paper
• Viral Vectors for Gene Therapy

  2020cites this paper
• Single-Domain Antibodies: Biology, Engineering and Emerging Applications

  2020cites this paper
• Hepatotoxicity and Toxicology of In Vivo Lentiviral Vector Administration in Healthy and Liver-Injury Mouse Models

  2019cites this paper
• REVIEW genome editing in animals using AAV-CRISPR system : In vivo applications to translational research of human disease

  2019cites this paper
• Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model

  2019cites this paper
• Generation of a caged lentiviral vector through an unnatural amino acid for photo-switchable transduction

  2019cites this paper
• [A method for efficient transduction of miR-483-5p in the kidney of mice].

  2018cites this paper
• Stable Expression by Lentiviral Transduction of Cells.

  2018cites this paper
• 利用CRISPR/Cas9慢病毒系统构建肺部EZH2基因敲除小鼠

  2018cites this paper
• BCSG 1 siRNA delivered by lentiviral vector suppressed proliferation and migration of MDA-MB-231 cells

  2018cites this paper
• BCSG1 siRNA delivered by lentiviral vector suppressed proliferation and migration of MDA-MB-231 cells.

  2017cites this paper
• Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy

  2017cites this paper
• In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease

  2017cites this paper
• Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center.

  2017cites this paper
• Mechanisms of recognition of HIV-infected cells by CD8+ T cells that mediate effective antiviral responses

  2017cites this paper
• PTTG, PBF and P53 in head and neck cancer

  2017cites this paper
• Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine

  2017cites this paper
• Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.

  2017cites this paper
• Genetically Engineered Dental Stem Cells for Regenerative Medicine

  2016cites this paper
• Long-Term Safety Follow-Up of Subjects Previously Treated with Non-Replicating Retroviral Vector-Based Gene Therapies

  2016cites this paper
• Surface modification via strain-promoted click reaction facilitates targeted lentiviral transduction.

  2016cites this paper
• Paralleled comparison of vectors for the generation of CAR-T cells

  2016cites this paper
• Delivery of RNA-based molecules to human hematopoietic stem and progenitor cells for modulation of gene expression.

  2016cites this paper
• Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease

  2016cites this paper
• Generation of diverse neural cell types through direct conversion.

  2016cites this paper
• Strategies for the Gene Modification of Megakaryopoiesis and Platelets

  2016cites this paper
• Genetic and functional characterisation of Immunoglobulin Heavy Chain Locus-CCAAT enhancer binding protein B-Cell acute lymphoblastic leukaemia

  2016cites this paper
• Gene Therapy of Malignant Glioma Hanna Stedt Gene Therapy of Malignant Glioma Alternative Strategies and Combination Therapies

  2015cites this paper
• Towards a commercial process for the manufacture of genetically modified T cells for therapy

  2015cites this paper
• Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy

  2015cites this paper
• [Construction of a lentiviral vector of FoxM1 shRNA and its transfection into human prostate cancer cell lines in vitro].

  2015cites this paper
• Expression of a biotin acceptor peptide-containing protein with potential incorporation on the lentiviral envelope as a viral surface engineering platform

  2015cites this paper
• Successful Generation of Hepatitis B virus (HBV) Pseudotype Particle; A Versatile Tool for Identification of the HBV Receptor and Investigation of HBV Infectivity

  2015cites this paper
• Engineered T cell therapies

  2015cites this paper
• Tightly regulated ‘all-in-one’ lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy

  2015cites this paper
• Advancing lentiviral gene therapy vectors for β-thalassaemia

  2015cites this paper
• Surface Remodeling of Lentiviral and Adeno-Associated Viral Vectors via Metabolically Introduced Bioorthogonal Functionalities

  2015influential citation
• Genetic Manipulation Via Gene Transfer

  2015cites this paper
• Reprogramming of Equine Adipose-Derived Stem Cells into Induced Neuronal and Schwann Cells by Lentiviral Vector Expression of Specific Transcription Factors

  2015cites this paper
• Microscale characterisation of a manufacturing route for lentiviral vectors

  2015cites this paper
• Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery.

  2015cites this paper
• Insect Biotechnology

  2015cites this paper
• Immune suppression in multiple myeloma : strategies to overcome NK cell inhibition

  2014influential citation
• Evaluation of new lentiviral vector pseudotypes for gene transfer into hematopoietic cells

  2014cites this paper
• EZH 2 suppresses hepatocellular differentiation of mouse bone marrow mesenchymal stem cells

  2014cites this paper
• Efficient transduction of equine adipose-derived mesenchymal stem cells by VSV-G pseudotyped lentiviral vectors.

  2014cites this paper
• Quantitative Shearing Linear Amplification Polymerase Chain Reaction: An Improved Method for Quantifying Lentiviral Vector Insertion Sites in Transplanted Hematopoietic Cell Systems

  2014cites this paper
• A method to mathematically determine transduction efficiency of lentivirus in HeLa cells

  2014cites this paper
• Effect of NELL1 gene overexpression in iPSC-MSCs seeded on calcium phosphate cement.

  2014cites this paper
• Lentiviral vectors encoding zinc-finger nucleases specific for the model target locus HPRT1.

  2014cites this paper
• EZH2 suppresses hepatocellular differentiation of mouse bone marrow mesenchymal stem cells.

  2014cites this paper
• Embryo development, fetal growth and postnatal phenotype of eGFP lambs generated by lentiviral transgenesis

  2014cites this paper
• Genetic amplification of PPME1 in gastric and lung cancer and its potential as a novel therapeutic target

  2014cites this paper
• Fibril formation by naturally occurring prostatic acid phosphatase fragments and their effect on viral infection and transduction

  2014cites this paper
• The role of HNF4α in Barrett’s metaplasia development

  2014cites this paper
• Ex Vivo Gene Therapy

  2014cites this paper
• Development of a Liver Gene Therapy Strategy for Haemophilia B With Lentiviral Vectors

  2013cites this paper
• Rapid Generation of Stable Cell Lines Expressing High Levels of Erythropoietin, Factor VIII, and an Antihuman CD20 Antibody Using Lentiviral Vectors

  2013cites this paper
• Lentivirus mediated GOLPH3 shRNA inhibits growth and metastasis of esophageal squamous cancer.

  2013cites this paper
• Gene Therapy for Melanoma: Progress and Perspectives

  2013influential citation
• Comparing nanodroplets and microbubbles for enhancing ultrasound-mediated gene transfection

  2013cites this paper
• Migratory properties of mesenchymal stem cells.

  2013cites this paper
• Baculovirus: an insect-derived vector for diverse gene transfer applications.

  2013cites this paper
• Estrogen receptor beta treats Alzheimer's disease

  2013cites this paper
• Viral vectors: a look back and ahead on gene transfer technology.

  2013cites this paper
• High Efficiency Restriction Enzyme–Free Linear Amplification-Mediated Polymerase Chain Reaction Approach for Tracking Lentiviral Integration Sites Does Not Abrogate Retrieval Bias

  2013cites this paper
• Histone Deacetylase Inhibition Activates Transgene Expression from Integration-Defective Lentiviral Vectors in Dividing and Non-Dividing Cells

  2013cites this paper
• Adiponectin-induced Inhibition of Intrinsic and Extrinsic Apoptotic Pathways Protects Pancreatic β-Cells Against Apoptosis

  2013cites this paper
• Nucleic Acid Delivery: Lentiviral and Retroviral Vectors

  2013cites this paper
• Lentiviral Vector-Mediated siRNA Knockdown of c-MYC: Cell Growth Inhibition and Cell Cycle Arrest at G2/M Phase in Jijoye Cells

  2013cites this paper
• New developments in lentiviral vector design, production and purification

  2013cites this paper
• Therapeutic Potential of Small Molecule MicroRNA Inhibition.

  2013cites this paper
• Targeted Lentiviral Vectors: Current Applications and Future Potential

  2013cites this paper
• Gene therapy for psychiatric disorders.

  2013cites this paper
• Lentiviral vectors and cardiovascular diseases: a genetic tool for manipulating cardiomyocyte differentiation and function

  2012cites this paper
• The Determination of Importance of Sequences Neighboring the Psi Sequence in Lentiviral Vector Transduction and Packaging Efficiency

  2012cites this paper
• Advances in Lentiviral Vector-based Cell Therapy with Mesenchymal Stem Cells

  2012cites this paper
• Specific Targeting of Human Interleukin (IL)-13 Receptor α2-Positive Cells with Lentiviral Vectors Displaying IL-13

  2012cites this paper
• Genetically Modified Organisms: Concepts and Methods

  2012cites this paper
• Quantification of Reverse Transcriptase Activity by Real-Time PCR as a Fast and Accurate Method for Titration of HIV, Lenti- and Retroviral Vectors

  2012cites this paper
• A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections

  2012cites this paper
• Efficacy and Site-Specificity of Adenoviral Vector Integration Mediated by the Phage φC31 Integrase

  2012cites this paper